---
title: "PPHC Shareholders Approve Board Slate and Governance Measures at AGM"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286128247.md"
description: "Public Policy Holding Co., Inc. (GB:PPHC) announced that shareholders approved all resolutions at the recent Annual General Meeting, including the election of new Class II directors and the ratification of Forvis Mazars as the auditor. The company is recognized for its advisory services in regulatory risk management. Analysts rate PPHC stock as a Buy with a price target of £1350.00, while Spark's AI Analyst gives it a Neutral score due to mixed financial indicators. PPHC operates globally, serving around 1,400 clients across various sectors."
datetime: "2026-05-12T15:42:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286128247.md)
  - [en](https://longbridge.com/en/news/286128247.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286128247.md)
---

# PPHC Shareholders Approve Board Slate and Governance Measures at AGM

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Public Policy Holding Co., Inc. ( (GB:PPHC) ) has shared an announcement.

Public Policy Holding Company, Inc., a dual-listed strategic communications and public affairs group, offers advisory services to corporations, trade associations and NGOs seeking to manage regulatory risk and shape policy outcomes. Its diversified client base and multi-sector reach position the firm as a key intermediary between businesses, policymakers and stakeholders in major regulated industries.

At its latest Annual General Meeting, shareholders approved all resolutions, including the election of Roeland Smits, Kathleen Casey and Benjamin Ginsberg as Class II directors through 2029. Investors also ratified Forvis Mazars as the company’s auditor and backed the move to electronic distribution of reports, signaling strong support for the current governance structure and operational efficiency measures.

The most recent analyst rating on (GB:PPHC) stock is a Buy with a £1350.00 price target. To see the full list of analyst forecasts on Public Policy Holding Co., Inc. stock, see the GB:PPHC Stock Forecast page.

**Spark’s Take on PPHC Stock**

According to Spark, TipRanks’ AI Analyst, PPHC is a Neutral.

The score is driven primarily by resilient cash generation and positive earnings-call guidance around sustained growth, margins, and strong free-cash-flow conversion. These positives are tempered by ongoing GAAP losses and a weakening leverage trend, while technicals are mixed/soft and valuation is constrained by a negative P/E despite a modest dividend yield.

To see Spark’s full report on PPHC stock, click here.

**More about Public Policy Holding Co., Inc.**

Public Policy Holding Company, Inc. is a global strategic communications platform providing government relations, public affairs, corporate communications, research and analytics, digital advocacy, and compliance support. Serving around 1,400 clients across sectors such as healthcare, financial services, energy, technology, telecoms and transportation, it operates from 18 offices in the United States and internationally, with shares listed on Nasdaq and London’s AIM market.

**Average Trading Volume:** 16,904

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** £288.5M

Find detailed analytics on PPHC stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [PPHC.US](https://longbridge.com/en/quote/PPHC.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Oppenheimer Sticks to Its Buy Rating for Public Policy Holding Co., Inc. (PPHC)](https://longbridge.com/en/news/286260983.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)](https://longbridge.com/en/news/286679129.md)